Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Ming Spring Kong

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 16, 2023
Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic Radiation Therapy in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisYinnan Meng, Han Sun, Sichao Wang, et al.
Hematology/Oncology Clinics of North America|November 20, 2019
Radiation Therapy for Thoracic MalignanciesVictor Ho-Fun Lee, Li Yang, Yong Jiang, et al.
Future Oncology (London, England)|November 24, 2017
Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer?Monica Cheng, Greg Durm, Nasser Hanna, et al.
Medical Review (2021)|August 21, 2025
Artificial intelligence-powered innovations in radiotherapy: boosting efficiency and efficacyJunyi Chen, Xinlin Zhu, Jian-Yue Jin, et al.
Frontiers in Oncology|July 31, 2023
The predictive role of soluble programmed death ligand 1 in digestive system cancersJian Ruan, Zhihong Zhao, Yuting Qian, et al.
Lung Cancer (Amsterdam, Netherlands)|July 31, 2012
Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CTJingbo Wang, Pawinee Mahasittiwat, Ka Kit Wong, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 10, 2017
Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United StatesMatthew P Smeltzer, Chun Chieh Lin, Feng-Ming Spring Kong, et al.
Frontiers in Oncology|December 5, 2019
Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment StrategyChi-Leung Chiang, Albert C Y Chan, Keith W H Chiu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2007
Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer - tumor motion and using internal target volume (ITV) could improve dose distribution in CTVJian-Yue Jin, Munther Ajlouni, Qing Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2020
Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?Jian-Yue Jin, Anxin Gu, Weili Wang, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|September 16, 2023
Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic Radiation Therapy in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisYinnan Meng, Han Sun, Sichao Wang, et al.
Hematology/Oncology Clinics of North America|November 20, 2019
Radiation Therapy for Thoracic MalignanciesVictor Ho-Fun Lee, Li Yang, Yong Jiang, et al.
Future Oncology (London, England)|November 24, 2017
Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer?Monica Cheng, Greg Durm, Nasser Hanna, et al.
Medical Review (2021)|August 21, 2025
Artificial intelligence-powered innovations in radiotherapy: boosting efficiency and efficacyJunyi Chen, Xinlin Zhu, Jian-Yue Jin, et al.
Frontiers in Oncology|July 31, 2023
The predictive role of soluble programmed death ligand 1 in digestive system cancersJian Ruan, Zhihong Zhao, Yuting Qian, et al.
Lung Cancer (Amsterdam, Netherlands)|July 31, 2012
Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CTJingbo Wang, Pawinee Mahasittiwat, Ka Kit Wong, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 10, 2017
Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United StatesMatthew P Smeltzer, Chun Chieh Lin, Feng-Ming Spring Kong, et al.
Frontiers in Oncology|December 5, 2019
Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment StrategyChi-Leung Chiang, Albert C Y Chan, Keith W H Chiu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2007
Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer - tumor motion and using internal target volume (ITV) could improve dose distribution in CTVJian-Yue Jin, Munther Ajlouni, Qing Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2020
Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?Jian-Yue Jin, Anxin Gu, Weili Wang, et al.
Pageof 17